Active	Status	Sponsor type	Region	Phase	Filter
3 Active 0 Inactive 3 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Wang, Zhiyi
SHINY, NCT06157502: Shuxuening Injection in the Treatment With Intravenous Thrombolysis in Patients With Ischemic Stroke	Recruiting	3	1380	RoW	Shuxuening Injection, Placebo	Beijing Tiantan Hospital	Ischemic Stroke, Acute	06/25	12/26
TAPIS, NCT06316570: Ticagrelor With Aspirin Dual Antiplatelet Therapy Combined With Intravenous Thrombolysis for Ischemic Stroke	Recruiting	3	1380	RoW	Early Dual Antiplatelet Therapy, Ticagrelor and Aspirin, Placebo, Placebo of Ticagrelor and Aspirin	Beijing Tiantan Hospital	Ischemic Stroke, Acute	12/25	12/26
Wu, Yanping
BRANT, NCT06037889: Efficacy and Safety of Tirofiban for Patients With BAD	Recruiting	3	516	RoW	Tirofiban, Tirofiban Hydrochloride and Sodium Chloride Injection, Aspirin tablet, Clopidogrel tablet	Peking Union Medical College Hospital, Pharmaron (Chengdu) Clinical Services Co., Ltd.	Branch Atheromatous Disease	07/25	10/25